These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10075988)

  • 1. Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells.
    Venturini F; Braspenning J; Homann M; Gissmann L; Sczakiel G
    Nucleic Acids Res; 1999 Apr; 27(7):1585-92. PubMed ID: 10075988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
    Tan TM; Gloss B; Bernard HU; Ting RC
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic activity of oligonucleotides with polarity and anomeric center reversal.
    Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
    Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.
    Alvarez-Salas LM; Cullinan AE; Siwkowski A; Hampel A; DiPaolo JA
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1189-94. PubMed ID: 9448307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.
    Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S
    Antiviral Res; 1994 Feb; 23(2):119-30. PubMed ID: 8147581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein.
    Böhm S; Wilczynski SP; Pfister H; Iftner T
    Int J Cancer; 1993 Nov; 55(5):791-8. PubMed ID: 8244576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
    Peto M; Tolle-Ersü I; Kreysch HG; Klock G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splice sites of human papillomavirus type 16 E6 gene or heterologous gene required for transformation by E7 and accumulation of E7 RNA.
    Belaguli NS; Pater MM; Pater A
    J Med Virol; 1995 Dec; 47(4):445-53. PubMed ID: 8636718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells.
    Hu G; Liu W; Mendelsohn J; Ellis LM; Radinsky R; Andreeff M; Deisseroth AB
    J Natl Cancer Inst; 1997 Sep; 89(17):1271-6. PubMed ID: 9293917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
    Steele C; Cowsert LM; Shillitoe EJ
    Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA combined with cisplatin inhibits cellular growth and induces apoptosis in HPV-positive head and neck cancer cells.
    Kojima Y; Otsuki N; Kubo M; Kitamoto J; Takata E; Saito H; Kosaka K; Morishita N; Uehara N; Shirakawa T; Nibu KI
    Cancer Gene Ther; 2018 Oct; 25(9-10):274-283. PubMed ID: 29795305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense human papillomavirus (HPV) E6/E7 expression, reduced stability of epidermal growth factor, and diminished growth of HPV-positive tumor cells.
    Rorke EA
    J Natl Cancer Inst; 1997 Sep; 89(17):1243-6. PubMed ID: 9293908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.